{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:49:04Z","timestamp":1789948144309,"version":"4.0.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2010,7,16]],"date-time":"2010-07-16T00:00:00Z","timestamp":1279238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8,16]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>In spite of advances in immunology on mycobacterial infection, there are few studies on the role of anti-microbial peptides in tuberculosis. The cathelin-related anti-microbial peptide (CRAMP) is the only cathelicidin isolated from mice. In this work we investigated the cellular sources and the production kinetics of this molecule during experimental tuberculosis, using two well-characterized models of latent or chronic infection and progressive disease. The lung of non-infected control mice expressed CRAMP at very low levels. In both models of experimental tuberculosis the main cells immunolabelled for CRAMP were bronchial epithelial cells, macrophages and pneumocytes types II and I. After intratracheal infection with a high bacilli dose (H37Rv strain) in Balb\/c mice to produce progressive disease, a high CRAMP gene expression was induced showing three peaks: very early after 1 day of infection, at day 21 when the peak of protective immunity in this model is raised, and at day 28 when the progressive phase starts and the immunoelectronmicroscopy study showed intense immunolabelling in the cell wall and cytoplasm of intracellular bacilli, as well as in cytoplasmic vacuoles. Interestingly, at day 60 post-infection, when advanced progressive disease is well established, characterized by high bacillary loads and extensive tissue damage, CRAMP gene expression decreased but strong CRAMP immunostaining was detected in vacuolated macrophages filled with bacilli. Thus, cathelecidin is highly produced during experimental pulmonary tuberculosis from diverse cellular sources and could have significant participation in its pathogenesis.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2010.04199.x","type":"journal-article","created":{"date-parts":[[2010,7,16]],"date-time":"2010-07-16T08:28:57Z","timestamp":1279268937000},"page":"542-550","source":"Crossref","is-referenced-by-count":34,"title":["Kinetics and cellular sources of cathelicidin during the course of experimental latent tuberculous infection and progressive pulmonary tuberculosis"],"prefix":"10.1093","volume":"161","author":[{"given":"J","family":"Casta\u00f1eda-Delgado","sequence":"first","affiliation":[{"name":"Medical Research Unit-Zacatecas, Mexican Institute of Social Security (IMSS), Zacatecas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Hern\u00e1ndez-Pando","sequence":"additional","affiliation":[{"name":"Experimental Pathology Section, Department of Pathology, National Institute of Medical Sciences and Nutrition SZ, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C J","family":"Serrano","sequence":"additional","affiliation":[{"name":"Medical Research Unit-Zacatecas, Mexican Institute of Social Security (IMSS), Zacatecas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Aguilar-Le\u00f3n","sequence":"additional","affiliation":[{"name":"Experimental Pathology Section, Department of Pathology, National Institute of Medical Sciences and Nutrition SZ, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Le\u00f3n-Contreras","sequence":"additional","affiliation":[{"name":"Experimental Pathology Section, Department of Pathology, National Institute of Medical Sciences and Nutrition SZ, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Rivas-Santiago","sequence":"additional","affiliation":[{"name":"Experimental Pathology Section, Department of Pathology, National Institute of Medical Sciences and Nutrition SZ, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"M\u00e9ndez","sequence":"additional","affiliation":[{"name":"Medical Research Unit-Zacatecas, Mexican Institute of Social Security (IMSS), Zacatecas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Gonz\u00e1lez-Curiel","sequence":"additional","affiliation":[{"name":"Medical Research Unit-Zacatecas, Mexican Institute of Social Security (IMSS), Zacatecas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Enciso-Moreno","sequence":"additional","affiliation":[{"name":"Medical Research Unit-Zacatecas, Mexican Institute of Social Security (IMSS), Zacatecas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Rivas-Santiago","sequence":"additional","affiliation":[{"name":"Medical Research Unit-Zacatecas, Mexican Institute of Social Security (IMSS), Zacatecas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,7,16]]},"reference":[{"key":"2021122708485850000_b1","first-page":"283","article-title":"The measurement and estimation of tuberculosis mortality","volume":"13","author":"Korenromp","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"2021122708485850000_b2","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S1473-3099(03)00741-2","article-title":"Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection","volume":"3","author":"Tufariello","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"2021122708485850000_b3","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1128\/IAI.73.8.4505-4511.2005","article-title":"Human {beta}-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells","volume":"73","author":"Rivas-Santiago","year":"2005","journal-title":"Infect Immun"},{"key":"2021122708485850000_b4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-3083.2008.02088.x","article-title":"The potential role of lung epithelial cells and beta-defensins in experimental latent tuberculosis","volume":"67","author":"Rivas-Santiago","year":"2008","journal-title":"Scand J Immunol"},{"key":"2021122708485850000_b5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1086\/506454","article-title":"beta-Defensin gene expression during the course of experimental tuberculosis infection","volume":"194","author":"Rivas-Santiago","year":"2006","journal-title":"J Infect Dis"},{"key":"2021122708485850000_b6","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.bbamem.2006.03.030","article-title":"LL-37, the only human member of the cathelicidin family of antimicrobial peptides","author":"Durr","year":"2006; 1758","journal-title":"Biochim Biophys Acta"},{"key":"2021122708485850000_b7","doi-asserted-by":"crossref","first-page":"13088","DOI":"10.1074\/jbc.272.20.13088","article-title":"Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse","volume":"272","author":"Gallo","year":"1997","journal-title":"J Biol Chem"},{"key":"2021122708485850000_b8","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0196-9781(01)00499-5","article-title":"Processing site and gene structure for the murine antimicrobial peptide CRAMP","volume":"22","author":"Pestonjamasp","year":"2001","journal-title":"Peptides"},{"key":"2021122708485850000_b9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/MOH.0b013e32831ac517","article-title":"The roles of cathelicidin LL-37 in immune defences and novel clinical applications","volume":"16","author":"Nijnik","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"2021122708485850000_b10","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.4049\/jimmunol.179.4.2060","article-title":"Cutting edge: vitamin d-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin","volume":"179","author":"Liu","year":"2007","journal-title":"J Immunol"},{"key":"2021122708485850000_b11","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1126\/science.1123933","article-title":"Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response","volume":"311","author":"Liu","year":"2006","journal-title":"Science"},{"key":"2021122708485850000_b12","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/IAI.01218-07","article-title":"Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells","volume":"76","author":"Rivas-Santiago","year":"2008","journal-title":"Infect Immun"},{"key":"2021122708485850000_b13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3109\/10520298009067249","article-title":"The use of fluorescein diacetate and ethidium bromide as a stain for evaluating viability of mycobacteria","volume":"55","author":"Jarnagin","year":"1980","journal-title":"Stain Technol"},{"key":"2021122708485850000_b14","first-page":"26","article-title":"Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis","volume":"89","author":"Hernandez-Pando","year":"1996","journal-title":"Immunology"},{"key":"2021122708485850000_b15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"2021122708485850000_b16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jsbmb.2006.12.052","article-title":"Vitamin D in the treatment of pulmonary tuberculosis","volume":"103","author":"Martineau","year":"2007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2021122708485850000_b17","first-page":"273","article-title":"[Neutrophil participation in early control and immune activation during experimental pulmonary tuberculosis]","volume":"142","author":"Barrios-Payan","year":"2006","journal-title":"Gac Med Mex"},{"key":"2021122708485850000_b18","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/intimm\/dxl107","article-title":"The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands","volume":"18","author":"Kandler","year":"2006","journal-title":"Int Immunol"},{"key":"2021122708485850000_b19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.0959-9673.2004.00381.x","article-title":"In situ analysis of lung antigen-presenting cells during murine pulmonary infection with virulent Mycobacterium tuberculosis","volume":"85","author":"Pedroza-Gonzalez","year":"2004","journal-title":"Int J Exp Pathol"},{"key":"2021122708485850000_b20","doi-asserted-by":"crossref","first-page":"7684","DOI":"10.4049\/jimmunol.179.11.7684","article-title":"Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways","volume":"179","author":"Yu","year":"2007","journal-title":"J Immunol"},{"key":"2021122708485850000_b21","first-page":"1027","article-title":"The potential of human neutrophil peptides in tuberculosis therapy","volume":"7","author":"Fu","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"2021122708485850000_b22","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1086\/424463","article-title":"Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy","volume":"190","author":"Kalita","year":"2004","journal-title":"J Infect Dis"},{"key":"2021122708485850000_b23","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/iai.64.3.926-932.1996","article-title":"In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis","volume":"64","author":"Miyakawa","year":"1996","journal-title":"Infect Immun"},{"key":"2021122708485850000_b24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1034\/j.1399-3003.2000.16a20.x","article-title":"Antibacterial activity of human neutrophil peptide-1 against Mycobacterium tuberculosis H37Rv: in vitro and ex vivo study","volume":"16","author":"Sharma","year":"2000","journal-title":"Eur Respir J"},{"key":"2021122708485850000_b25","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.peptides.2004.04.003","article-title":"In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis","volume":"25","author":"Fattorini","year":"2004","journal-title":"Peptides"},{"key":"2021122708485850000_b26","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1046\/j.1365-2567.1997.00193.x","article-title":"Analysis of the local kinetics and localization of interleukin-1 alpha, tumour necrosis factor-alpha and transforming growth factor-beta, during the course of experimental pulmonary tuberculosis","volume":"90","author":"Hernandez-Pando","year":"1997","journal-title":"Immunology"},{"key":"2021122708485850000_b27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2567.2002.01403.x","article-title":"The role of prostaglandin E2 in the immunopathogenesis of experimental pulmonary tuberculosis","volume":"106","author":"Rangel Moreno","year":"2002","journal-title":"Immunology"},{"key":"2021122708485850000_b28","doi-asserted-by":"crossref","first-page":"5788","DOI":"10.4049\/jimmunol.0901491","article-title":"Human cathelicidin peptide LL-37 modulates the effects of IFN-gamma on APCs","volume":"183","author":"Nijnik","year":"2009","journal-title":"J Immunol"},{"key":"2021122708485850000_b29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-2249.2002.01832.x","article-title":"Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis","volume":"128","author":"Arriaga","year":"2002","journal-title":"Clin Exp Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2010.04199.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/161\/3\/542\/41924613\/j.1365-2249.2010.04199.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/161\/3\/542\/41924613\/j.1365-2249.2010.04199.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:22:14Z","timestamp":1641054134000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/161\/3\/542\/6438670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,16]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2010,7,16]]},"published-print":{"date-parts":[[2010,8,16]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04199.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2010,9]]},"published":{"date-parts":[[2010,7,16]]}}}